NCT06756282

Brief Summary

Pace maker implantation after the procedure of TAVR can be estimated at 15% of patients. However, some studies have shown that the conduction disturbances after TAVR could resolve over time, and that roughly between one- and two-thirds of patients who required a permanent pace maker implantation post TAVR were not found to be dependent at subsequent follow-up. This study aims to evaluate a cohort of patients permanently implanted with a pacemaker post-TAVR for high-grade conductive disorders and to describe the prevalence of effective pacemaker stimulation at 1 year follow-up. Secondary objectives include the evaluation of the prevalence of effective stimulation 3 months after implantation of the pace maker , description of the types of conductive disorders associated with atrial and/or ventricular stimulation, description of the initial indication for pacemaker implantation, description of the characteristics of the population with or without stimulation dependency. The objective is to better rationalize indication of permanent stimulation after TAVI

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
17mo left

Started Nov 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Nov 2024Oct 2027

Study Start

First participant enrolled

November 13, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 31, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 13, 2027

Expected
Last Updated

January 3, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

December 31, 2024

Last Update Submit

January 2, 2025

Conditions

Keywords

transcatheter aortic valve replacement (TAVR)permanent pacingconductive disorderspacing dependency

Outcome Measures

Primary Outcomes (1)

  • pacing dependency at 1 year follow-up

    pacing dependency is defined: 1. escape QRS rhythm \< 30 bpm 2. High degree atrioventricular block (paroxysmal or permanent) 3. Atrial fibrillation with escape rhythm \<40/min

    6 months

Study Arms (1)

Patients who need permanent pace maker implantation after TAVR

patients with high degree conductive disorders after TAVR who required pacemaker implantation before discharge the study will evaluated pacing dependency at one year (main objective) and the profile of patients with pacing dependency (type of initial conductive disorder, clinical characteristics)

Procedure: Pacemaker and defibrillator

Interventions

only patients with pacemaker implantation will be evaluated in the study

Patients who need permanent pace maker implantation after TAVR

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who have TAVR and who are considered to need permanent pacemaker implantation before hospital discharge relating to high degree, symptomatic or not, conductive disorders

You may qualify if:

  • all patients who need a permanent pacemaker implantation after TAVR

You may not qualify if:

  • Patients who have already a pace maker before TAVR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Montpellier

Montpellier, 34295, France

RECRUITING

Related Links

MeSH Terms

Conditions

Aortic Valve Stenosis

Interventions

Defibrillators

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Intervention Hierarchy (Ancestors)

ElectrodesElectrical Equipment and SuppliesEquipment and Supplies

Central Study Contacts

Florence Leclercq, PUPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 31, 2024

First Posted

January 1, 2025

Study Start

November 13, 2024

Primary Completion

October 1, 2025

Study Completion (Estimated)

October 13, 2027

Last Updated

January 3, 2025

Record last verified: 2025-01

Locations